Coloplast (COLO B)

Executive Summary

Coloplast A/S develops and markets intimate healthcare products and services worldwide. More Details


PE ratio (47.1x) is below the Medical Equipment industry average (64.5x)

Earnings are forecast to grow 9.17% per year

Earnings grew by 8.3% over the past year

Risk Analysis

Dividend of 1.94% is not well covered by earnings

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

Similar Companies

Search for a company to compare.